Targeting toxins to neural antigens and receptors.
Wiley
R G
RG
Neurology Service, VAMC, and Vanderbilt University, Nashville, TN, USA.
D000544:Alzheimer Disease / Q000378:metabolism; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D000941:Antigens / Q000187:drug effects*; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000473:pathology; D004195:Disease Models, Animal; D018796:Immunoconjugates; D000922:Immunotoxins / Q000737:chemistry / Q000494:pharmacology*; D009699:N-Glycosyl Hydrolases; D009410:Nerve Degeneration; D009419:Nerve Tissue Proteins / Q000187:drug effects* / Q000276:immunology; D009498:Neurotoxins / Q000494:pharmacology*; D011689:Purkinje Cells / Q000187:drug effects; D051381:Rats; D017475:Receptors, Nerve Growth Factor / Q000187:drug effects* / Q000276:immunology; D017981:Receptors, Neurotransmitter / Q000187:drug effects* / Q000276:immunology; D054789:Ribosome Inactivating Proteins, Type 1; D000076985:Saporins; D018800:Thy-1 Antigens / Q000187:drug effects
C085696:192 IgG-saporin; D000911:Antibodies, Monoclonal; D000941:Antigens; D018796:Immunoconjugates; D000922:Immunotoxins; D009419:Nerve Tissue Proteins; D009498:Neurotoxins; C085346:OX7-saporin; D017475:Receptors, Nerve Growth Factor; D017981:Receptors, Neurotransmitter; D054789:Ribosome Inactivating Proteins, Type 1; D018800:Thy-1 Antigens; C101397:anti-dopamine beta-hydroxylase immunotoxin; D009699:N-Glycosyl Hydrolases; D000076985:Saporins